| Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial CJ Fisher, JFA Dhainaut, SM Opal, JP Pribble, RA Balk, GJ Slotman, ... Jama 271 (23), 1836-1843, 1994 | 1354 | 1994 |
| Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial E Abraham, R Wunderink, H Silverman, TM Perl, S Nasraway, H Levy, ... Jama 273 (12), 934-941, 1995 | 1207 | 1995 |
| Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death E Abraham, PF Laterre, R Garg, H Levy, D Talwar, BL Trzaskoma, ... New England Journal of Medicine 353 (13), 1332-1341, 2005 | 1136 | 2005 |
| Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, doubleblind, placebo-controlled, multicenter trial SM Opal, CJ Fisher, JFA Dhainaut, JL Vincent, R Brase, SF Lowry, ... Critical care medicine 25 (7), 1115-1124, 1997 | 1079 | 1997 |
| Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock E Abraham, A Anzueto, G Gutierrez, S Tessler, G San Pedro, ... The Lancet 351 (9107), 929-933, 1998 | 881 | 1998 |
| Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial S Nadel, B Goldstein, MD Williams, H Dalton, M Peters, WL Macias, ... The Lancet 369 (9564), 836-843, 2007 | 514 | 2007 |
| Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis EW Ely, PF Laterre, DC Angus, JD Helterbrand, H Levy, JF Dhainaut, ... Critical care medicine 31 (1), 12-19, 2003 | 365 | 2003 |
| Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome CJ Peters, MD, GL Simpson, MD, PhD, MPH, H Levy, MD, PhD Annual review of medicine 50 (1), 531-545, 1999 | 364 | 1999 |
| A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis … JL Vincent, MK Ramesh, D Ernest, SP LaRosa, J Pachl, N Aikawa, ... Critical care medicine 41 (9), 2069-2079, 2013 | 339 | 2013 |
| Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study PF Laterre, G Garber, H Levy, R Wunderink, GT Kinasewitz, JP Sollet, ... Critical care medicine 33 (5), 952-961, 2005 | 277 | 2005 |
| Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated) SM Opal, GE Garber, SP LaRosa, DG Maki, RC Freebairn, GT Kinasewitz, ... Clinical infectious diseases 37 (1), 50-58, 2003 | 248 | 2003 |
| Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127): results of a randomized, double-blind, placebo … AM Fein, GR Bernard, GJ Criner, EC Fletcher, JT Good, WA Knaus, ... Jama 277 (6), 482-487, 1997 | 241 | 1997 |
| Cardiopulmonary manifestations of hantavirus pulmonary syndrome GW Hallin, SQ Simpson, RE Crowell, DS James, FT Koster, GJ Mertz, ... Critical care medicine 24 (2), 252-258, 1996 | 235 | 1996 |
| A reevaluation of sputum microscopy and culture in the diagnosis of pulmonary tuberculosis H Levy, C Feldman, H Sacho, H van der Meulen, J Kallenbach, ... Chest 95 (6), 1193-1197, 1989 | 233 | 1989 |
| Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis LS Chawla, MG Seneff, DR Nelson, M Williams, H Levy, PL Kimmel, ... Clinical Journal of the American Society of Nephrology 2 (1), 22-30, 2007 | 219 | 2007 |
| Extended evaluation of recombinant human activated protein C United States Trial (ENHANCE US): a single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in … GR Bernard, BD Margolis, HM Shanies, EW Ely, AP Wheeler, H Levy, ... Chest 125 (6), 2206-2216, 2004 | 219 | 2004 |
| The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis H Levy, DA Horak, BR Tegtmeier, SB Yokota, SJ Forman Respiratory medicine 86 (3), 243-248, 1992 | 214 | 1992 |
| Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America GJ Mertz, L Miedzinski, D Goade, AT Pavia, B Hjelle, CO Hansbarger, ... Clinical infectious diseases 39 (9), 1307-1313, 2004 | 209 | 2004 |
| Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial E Abraham, R Baughman, E Fletcher, S Heard, J Lamberti, H Levy, ... Critical care medicine 27 (8), 1478-1485, 1999 | 188 | 1999 |
| Equal aspiration rates in gastrically and transpylorically fed critically ill patients J Esparza, MA Boivin, MF Hartshorne, H Levy Intensive Care Medicine 27, 660-664, 2001 | 162 | 2001 |
